SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-08-000033
Filing Date
2008-05-28
Accepted
2008-05-28 13:55:01
Documents
1
Period of Report
2008-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 19041
  Complete submission text file 0000875320-08-000033.txt   20818
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 100 EUROPA DRIVE STE 170 CHAPEL HILL NC 27514
Business Address 100 EUROPA DRIVE SUITE 170 CHAPEL HILL NC 27514 9199326998
SANDERS CHARLES A (Reporting) CIK: 0001022936 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 08863082